Previous studies have shown that activation of NLRP3 inflammasome is observed in HDM and fungi-induced asthma, and NLRP3 inflammasome inhibition mitigates asthmatic symptoms such as Th2 cytokine release, airway hyperresponse, and inflammatory responses [28,55]. This evidence concerns the gene NLRP3 and asthma.